Within the body, the intestinal epithelium plays a number of important features such as digest and absorb nutrients, provides a physical barrier and shields the body from the challenging conditions of the gut lumen. The epithelial barrier secure selectivity, preventing potentially harmful luminal contents by rejection, meanwhile facilitating a controlled absorption and secretion of significant amounts of solutes and water in a specific direction. Individual epithelial cells are linked through a network of intercellular junctions - tight junction (TJ) which holds particular significance in defining the attributes of the paracellular barrier and its selectivity (Ma et al., 2018). To determine barrier strength, transepithelial electrical resistance (TEER) is commonly measured in in vitro cell models and permeability to paracellular markers such as the enzyme horseradish peroxidase, inulin or mannitol is assessed (Bernardini et al., 2021). Our results revealed that basolateral infection in the form of LPS had an effect on the reduction of TEER values already after 6 h of application. The fact that basolateral infection of cells with entero-invasive bacteria leads to a significant decrease in TEER was also demonstrated by Wine et al. (2009), who found that the basolateral aspect of the T84 cell line by infection with invasive E. coli (O157:H7) led to a significant decrease in TEER values. This reduction was more significant after basolateral application compared to apical of entero-invasive E. coli (Wine et al., 2009). There is evidence that other pathogens, such as C. jejuni, enter intestinal epithelial cells from the basolateral membrane, highlighting the importance of this finding (Monteville and Konkel, 2002).
In addition, it is well know, that the intestinal barrier function is, to some extent, supported by TJ proteins (Capaldo et al., 2017). Epithelial cell TJs are comprised of numerous junctional molecules including claudins, occludin and zonula occludens, which govern the paracellular permeability of various macromolecules, ions, and water between neighboring cells. Occludin is a key transmembrane protein in TJs, and both occludin and claudin-1 play essential roles in maintaining intestinal permeability and barrier function of TJs. There is evidence demonstrating that inflammation induced by LPS disrupts the integrity of intestinal epithelial cells and TJs (Wu et al., 2020). Disruption of the integrity of TJs leads to immune cell activation and inflammation processes in affected tissues (Suzuki, 2020). With agreement of the previous statement, in our study, a basolateral application of LPS to MDM cells affected the expression of gene encoding OCLN which resulted in significant down-regulation in IPEC-J2 cells representing the apical compartment. Similar results were reported by Zhao et al. (2019) in their study after treating IPEC-J2 cells with bacterial LPS, where they observed a decrease in mRNA levels for gene encoding OCLN (Zhao et al., 2020). Comparably, in the work of Wu et al. (2020), by applying LPS at a concentration of 1 µg/mL, observed down-regulation of expression for genes encoding the proteins occludin and claudin-1 (Wu et al., 2020).
On the other hand, strong adhesion provides the initial interaction of probiotics with intestinal epithelial cells, which is key for LAB strains to exert their beneficial effects on host health. Adhesion to intestinal cells limits the presence of potential pathogens, thereby providing protection to intestinal epithelial cells (IECs) (Guan et al., 2020). The genus Limosilactobacillus (līmōsus, Lat. - slimy), which also includes the strains L. reuteri and L. fermentum, is characterized by the property of most strains of this genus to produce exopolysaccharides (EPS) from sucrose to promote biofilm formation on epithelia in the gut (Zheng et al., 2020). In this study L. fermentum CCM 7158 was used as an indicator LAB strain since it is included in the Czech Collection of Microorganisms (CCM) and its characteristics have been widely studied both in in vitro and in vivo conditions in previous studies (Capcarova et al., 2010; Hrnčár et al., 2021, 2014; Mudroňová et al., 2006). An interesting finding in our work is that simultaneous treatment of MDM cells with LPS and treatment of IPEC-J2 with probiotic strain L. fermentum CCM 7158 led to down-regulation of mRNA for CLDN-1 and OCLN in intestinal cells. However, when L. reuteri B1/1 was used, the mRNA levels for the above-mentioned genes were significantly increased compared to the control group of cells. Similarly, genes encoding the antimicrobial proteins LUM and OLFM-4, which are also involved in maintaining the integrity of the intestinal epithelial layer (Karamanou et al., 2018), were significantly up-regulated in the L. reuteri B1/1 treatment of IPEC-J2 cells. In light of these results, we suggest that L. reuteri B1/1 may acts in a stimulatory manner on intestinal epithelia. Comparably, in our recent study, we observed stimulatory effect of L. reuteri B1/1 on non-carcinogenic porcine derived enterocytes (CLAB) at both used concentrations (107 and 109 CFU/mL) for mRNA transcription levels of LUM and OLFM-4 (Karaffová et al., 2023).
At the same time, enterocytes are an important component of the highly regulated communication network that provides protection to the intestinal mucosa, their ability to recognize microorganisms by pattern recognition receptors (PRR) is essential (Kagnoff, 2014). The best known of these PRR are the Toll-like receptors (TLRs). Interaction of microorganisms with TLRs either leads to activation and triggering of the signaling pathway or, conversely, through the mechanism of negative regulators, blocks their activation (Gao and Li, 2017). Structural components of the LAB cell wall, as well as the EPS they are able to produce and release to the surrounding environment, are capable to interact with TLRs in the gut (Oerlemans et al., 2021). In our previous study with the IPEC-J2/moDCs co-culture model, we demonstrated the ability of L. reuteri Biocenol™ derived EPS applied to increase mRNA levels in dendritic cell monocultures (Kiššová et al., 2023). In the present work we used live lactobacilli, where by treating apically deposited IPEC-J2 cells with L. fermentum CCM 7158, we observed an increase in gene expression for the gene encoding the TLR4 receptor not only in directly treated enterocytes but also in basolaterally deposited MDM cells. Although the gene encoding TLR2 could not be captured in IPEC-J2 due to the reduced gene expression level, but the expression of this gene was increased in MDMs. This up-regulation in basolaterally deposited macrophages correlates with the detected increased expression for the studied pro-inflammatory cytokines (IL-1β, IL-6, IL-18), exactly in this experimental group. We hypothesize that this increase of genes encoding TLR receptors implies actively maintaining the host's vigilance against pathogens. Our results are not surprising at all, because it is well known that TLR signaling triggers an initial cytokine reaction which intensifies the inflammatory response in the host, while engaging other cells in the fight against infectious agents. Macrophages participate in cytokine production following their TLR9, TLR2 and TLR4 activation by releasing cytokines such as IL-12, IL-1β, IL-6 and IL-10 (Strieter et al., 2003; Hoogerwerf et al., 2010; Juarez et al., 2010).
Numerous investigations have demonstrated that LPS disrupts structural integrity of the intestinal epithelia, triggers inflammation, and leads to the release of inflammatory cytokines such as IL-1β, IL-8, IL-6 and TNF-α (Cao et al., 2018; Wu et al., 2018; Gao et al., 2019). The results obtained from our study by monitoring mRNA transcriptional levels of pro-inflammatory cytokines (IL-8, IL-1β, IL-6, IL-18) in LPS-treated experimental group indicate an increased release of cytokines by each cell type. Similarly, previous studies have shown that LPS is able to induce inflammation in intestinal epithelial cells which was manifested by an increased levels of the monitored pro-inflammatory cytokines (Sargeant et al., 2011; Dong et al., 2019; Qiu et al., 2019). When comparing transcriptional levels of the studied pro-inflammatory cytokines in cells exposed to LPS and cells treated with L. reuteri B1/1 is obvious that simultaneous treatment of IPEC-J2 cells with LAB and LPS infection of MDMs significantly suppressed the inflammation induced by LPS infection alone without probiotic treatment. An interesting finding of our work, however, was the different cellular responses of both IPEC-J2 and MDMs to the two LAB strains used. While L. reuteri B1/1 had the potential to increase the expression of genes encoding the antimicrobial peptides LUM and OLFM-4, as well as genes encoding TJ-related genes (CLDN-1 and OCLN), we did not observe these effects in the case of L. fermentum CCM 7158. On the contrary, L. fermentum CCM 7158 was able to increase the mRNA levels of pro-inflammatory cytokines (IL-18, IL-6 and IL-1β) in indirectly treated MDM cells. Along with evaluating gene expression of pro-inflammatory cytokines, IL-10 and essential anti-inflammatory cytokine was assessed. IL-10 plays a pivotal role in preserving gut homeostasis, fine balance between inflammation processes triggered by pathogens and play a role in facilitating immunoregulatory mechanisms triggered by probiotics (Kaji et al., 2018; Sheil et al., 2006). In our experiment, cells from both the apical and basolateral compartments showed increased gene expression for this anti-inflammatory cytokine for both probiotic strains used and applied to IPEC-J2 cells. Although production of the anti-inflammatory cytokine IL-10 was observed in both LAB strains used in both cell cultures, we hypothesize that L. fermentum CCM 7158 has both an anti-inflammatory and immunostimulatory potential as it was able to increase pro-inflammatory cytokines upon simultaneous treatment with LPS in DMD cells. Similarly, in the study by Huang et al. (2012), they found that the strain E. faecium EF1 exhibits both anti-inflammatory and immunostimulatory activities after oral administration in suckling piglets (Huang et al., 2012). The simultaneous anti- and pro-inflammatory properties of probiotics have also been demonstrated in several other in vitro studies (De Moreno De Leblanc et al., 2007; Haller et al., 2000). However, it must be taken into account that different strains of probiotics have different effects on cellular activity, cytokine release and immunological interactions. Therefore, it is important to test bacterial strains under in vitro conditions, which allows the selection of toxic bacteria in order to reduce the number of preclinical tests performed on animals (Huang et al., 2020).